MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,946,920 | -29.1% | 2,415,477 | -18.5% | 0.06% | -26.9% |
| Q1 2023 | $11,208,385 | -29.0% | 2,962,848 | +10.0% | 0.08% | -26.4% |
| Q4 2022 | $15,779,351 | -6.6% | 2,692,848 | +7.8% | 0.11% | -10.9% |
| Q3 2022 | $16,886,000 | +83.6% | 2,497,848 | +25.5% | 0.12% | +56.6% |
| Q2 2022 | $9,196,000 | +24.9% | 1,990,559 | +7.9% | 0.08% | +52.0% |
| Q1 2022 | $7,360,000 | -41.5% | 1,844,823 | -8.8% | 0.05% | -37.5% |
| Q4 2021 | $12,582,000 | -34.0% | 2,022,895 | 0.0% | 0.08% | -38.5% |
| Q3 2021 | $19,075,000 | -28.8% | 2,022,895 | +2.5% | 0.13% | -29.0% |
| Q2 2021 | $26,792,000 | -6.6% | 1,972,895 | +75.8% | 0.18% | -23.4% |
| Q1 2021 | $28,682,000 | -3.9% | 1,122,173 | +0.0% | 0.24% | +1.3% |
| Q4 2020 | $29,861,000 | +172.9% | 1,122,145 | +90.9% | 0.24% | +129.1% |
| Q3 2020 | $10,943,000 | -21.5% | 587,708 | -1.3% | 0.10% | -29.9% |
| Q2 2020 | $13,941,000 | +2354.4% | 595,743 | +1554.8% | 0.15% | +1370.0% |
| Q1 2018 | $568,000 | +188.3% | 36,000 | +200.0% | 0.01% | +233.3% |
| Q4 2017 | $197,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |